Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul-Aug;121(4):297-303.

Metabolic Bone Disease: An Overview

Catherine Gooch  1 , Paige Ekert  1 , Gary S Gottesman  2
Affiliations
Review

Metabolic Bone Disease: An Overview

Catherine Gooch et al. Mo Med. 2024 Jul-Aug.

Abstract

Metabolic bone diseases are a heterogenous group of conditions that all result in aberrant bone mineral homeostasis with resulting skeletal disease. The underlying causes are variable, ranging from nutritional deficiencies to pathogenic variants in skeletal genes. To properly diagnose and treat these conditions, a clinician needs to understand bone metabolism as well as recognize the signs of disease in a patient. This review will focus on three relatively common metabolic bone diseases (osteogenesis imperfecta, hypophosphatasia, and X-linked hypophosphatemic rickets) that are caused by genetic variants, not by nutritional deficiency. As molecular DNA sequencing has improved, the scientific community has been able to better understand the genetic basis of these conditions and create sophisticated medical treatments based on the genetic deficiency.

PubMed Disclaimer

Conflict of interest statement

Disclosure: No financial disclosures reported. Artificial intelligence was not used in the study, research, preparation, or writing of this manuscript.

Figures

Figure 1
Figure 1
Autosomal Dominant Pedigree (Most OI/Some HPP) Key: Shaded Affected; Unshaded Unaffected
Figure 2
Figure 2
Autosomal Recessive Pedigree (some OI/some HPP) Key: Shaded Affected; Unshaded Unaffected
Figure 3
Figure 3
X-linked Dominant Pedigree (XLH) Key: Shaded Affected; Unshaded Unaffected
None
See this image and copyright information in PMC

References

    1. Feng X. Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease. Current chemical biology. 2009;3(2):189–196. doi: 10.2174/187231309788166398. - DOI - PMC - PubMed
    1. Carvalho MS, Cabral JM, da Silva SCL, Vashishth D. Bone Matrix Non-Collagenous Proteins in Tissue Engineering: Creating New Bone by Mimicking the Extracellular Matrix. Polymers. 2021;13(7):1095. doi: 10.3390/polym13071095. - DOI - PMC - PubMed
    1. Charoenngam N, Nasr A, Shirvani A, Holick MF. Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management. Genes. 2022;1880;13(10) doi: 10.3390/genes13101880. - DOI - PMC - PubMed
    1. Wawrzyniak A, Balawender K. Structural and Metabolic Changes in Bone. Animals : an open access journal from MDPI. 2022;1946;12(15) doi: 10.3390/ani12151946. - DOI - PMC - PubMed
    1. Guo YC, Yuan Q. Fibroblast growth factor 23 and bone mineralisation. International journal of oral science. 2015;7(1):8–13. doi: 10.1038/ijos.2015.1. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources